ERBB2 and breast cancer: Four primary molecular subtypes of breast cancer (BC) are defined in large part by hormone receptors (HR) and human epidermal growth factor receptor 2 (HER2), namely, luminal A (HR+/HER2−), luminal B (HR+/HER2+), HER2+, and triple-negative BC (HR−/HER2−) [33].